ibrary study of kidney stone dissolving medicaments in Persian medicine and evaluation of a related multi-ingredient formulation in dissolving calcium kidneystones; a double-blind randomized clinical trial
Phase 3
Recruiting
- Conditions
- renal stone.
- Registration Number
- IRCT20191212045709N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 18 years and older
Calcium kidney stones with a size of 5 mm or more based on imaging results
Lack of confirmed history of acute renal failure
Lack of confirmed history of chronic kidney disease
having no present urinary tract infection
no concurrent use of medications including:®Sankol? ®Rowatinex and Cystone®
no pregnancy or breast feeding
Exclusion Criteria
Age 18 years and older
Calcium kidney stones with a size of 5 mm or more based on imaging results
Lack of confirmed history of acute renal failure
Lack of confirmed history of chronic kidney disease
having no present urinary tract infection
no concurrent use of medications including:®Sankol? ®Rowatinex and Cystone®
no pregnancy or breast feeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver function test- renal function test-Ca and P serum level, urine analysis, 24 hour urine volume and stone diameter. Timepoint: At the beginning of the study and one month after the end of the course of medication. Method of measurement: KUB- URINE ANALYSIS-BLOOD ANALYSIS.
- Secondary Outcome Measures
Name Time Method